Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meth

This article was originally published in The Tan Sheet

Executive Summary

Spectrum International and its two top execs plead guilty to distributing pseudoephedrine tablets "knowing or having reasonable cause to believe that [they] would be used to manufacture methamphetamine," U.S. Attorney in Los Angeles announces Oct. 23. Spectrum president Charles Eisele, along with his brother and VP Richard Eisele, distributed roughly 1.1 bil. Ephedrine Release and Ephrin Release tablets between June 1996 and January 1998 to firms that sent pills to meth labs. Billings, Mont.-based company will pay $2 mil. in forfeiture and fines. Defendants will be sentenced Feb. 7 by Los Angeles federal Judge Howard Matz and face a maximum sentence of four years in prison and a $250,000 fine
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel